Pollution of insulin with silicone oil, a hazard of disposable plastic syringes

Pressure pain perception at the injured foot: the impact of diabetic neuropathy.

Journal of musculoskeletal & neuronal interactions·2012

Quality of centralized diabetes care: a population-based study in the German Democratic Republic 1989-1990.

Acta diabetologica·1993

Risk of obesity in type II diabetes mellitus.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·1992

Large pericardial effusions in the acquired immunodeficiency syndrome.

Chest·1992

[Importance of calcium ions and calcium antagonists in affective psychoses].

Fortschritte der Neurologie-Psychiatrie·1992

[Epididymitis disclosing an idiopathic urethroseminal reflux in children].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·1992

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Lost and Found: Western Honey Bee (Apis mellifera) Matrix Metalloproteinase 1.

Ecology and evolution·2026

Bacterial effectors targeting the host ubiquitin system.

Biochemical Society transactions·2026

The Dual Nature of RNA Ligation and Degradation by T4 RNA Ligase 1: Insights Into an AMP-Driven, Nucleobase-Dependent Reverse Reaction.

Chembiochem : a European journal of chemical biology·2026

An Integrated Strategy to Reprogram NRPS Initiation Modules for Long-Chain Surfactin Biosynthesis.

Metabolic engineering·2026

Structural insights into peptidoglycan hydrolysis by the FtsEX system in Escherichia coli during cell division.

eLife·2026

Liquid crystalline nanoparticle-mediated co-delivery of gentamicin and rhDNase against mature Escherichia coli ATCC 25922 biofilms.

International journal of pharmaceutics·2026

Pollution of insulin with silicone oil, a hazard of disposable plastic syringes

Related Experiment Videos

Related Concept Videos

Pressure pain perception at the injured foot: the impact of diabetic neuropathy.

Quality of centralized diabetes care: a population-based study in the German Democratic Republic 1989-1990.

Risk of obesity in type II diabetes mellitus.

Large pericardial effusions in the acquired immunodeficiency syndrome.

[Importance of calcium ions and calcium antagonists in affective psychoses].

[Epididymitis disclosing an idiopathic urethroseminal reflux in children].

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lost and Found: Western Honey Bee (Apis mellifera) Matrix Metalloproteinase 1.

Bacterial effectors targeting the host ubiquitin system.

The Dual Nature of RNA Ligation and Degradation by T4 RNA Ligase 1: Insights Into an AMP-Driven, Nucleobase-Dependent Reverse Reaction.

An Integrated Strategy to Reprogram NRPS Initiation Modules for Long-Chain Surfactin Biosynthesis.

Structural insights into peptidoglycan hydrolysis by the FtsEX system in Escherichia coli during cell division.

Liquid crystalline nanoparticle-mediated co-delivery of gentamicin and rhDNase against mature Escherichia coli ATCC 25922 biofilms.

Pollution of insulin with silicone oil, a hazard of disposable plastic syringes

Related Experiment Videos

Related Concept Videos

Related Articles